Literature DB >> 3293983

Defective bone formation by transplanted Hyp mouse bone cells into normal mice.

B Ecarot-Charrier1, F H Glorieux, R Travers, M Desbarats, F Bouchard, A Hinek.   

Abstract

The hypophosphatemic (Hyp) mouse is a model for human X-linked hypophosphatemia (XLH). To test the hypothesis of an abnormal osteoblast function in XLH, periostea and osteoblasts isolated from normal and Hyp mice were transplanted im into normal and mutant mice. The thickness of the osteoid seams at the periphery of the bone nodules and the osteoid volume were measured in transplants as an index of bone formation. Impaired mineralization was evidenced in transplants of Hyp cells into Hyp mice by excessive osteoid thickness and volume compared with transplants of normal cells into normal mice. When normal cells were transplanted into mutant mice, the osteoid thickness and volume were markedly increased, demonstrating that the extracellular environment is critical for bone formation. In contrast, when Hyp cells were transplanted into normal mice, reduction, but not normalization, of the osteoid thickness and volume was observed. This abnormal bone formation supports the hypothesis of an osteoblast defect in the Hyp mouse.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293983     DOI: 10.1210/endo-123-2-768

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

Review 1.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

Review 2.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

3.  Response of jejunal phosphate absorption to 1,25-dihydroxyvitamin D(3) stimulationin vivo in young X-linked hypophosphatemic (Hyp) mice.

Authors:  R A Meyer; M H Meyer; R W Gray; B A Brault
Journal:  Endocrine       Date:  1995-03       Impact factor: 3.633

4.  Hormonal Regulation of Osteocyte Perilacunar and Canalicular Remodeling in the Hyp Mouse Model of X-Linked Hypophosphatemia.

Authors:  Danielle Tokarz; Janaina S Martins; Elizabeth T Petit; Charles P Lin; Marie B Demay; Eva S Liu
Journal:  J Bone Miner Res       Date:  2017-11-17       Impact factor: 6.741

5.  Osteogenesis by human osteoblastic cells in diffusion chamber in vivo.

Authors:  Y Gotoh; K Fujisawa; K Satomura; M Nagayama
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

6.  Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect.

Authors:  T Nesbitt; T M Coffman; R Griffiths; M K Drezner
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors:  Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal:  Bone       Date:  2006-06-09       Impact factor: 4.398

8.  Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice.

Authors:  L Rifas; L L Dawson; L R Halstead; M Roberts; L V Avioli
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

Review 9.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

10.  Hereditary hypophosphatemic rickets with hypercalciuria: a study for the phosphate transporter gene type IIc and osteoblastic function.

Authors:  Takehisa Yamamoto; Toshimi Michigami; Fumito Aranami; Hiroko Segawa; Kousei Yoh; Shigeo Nakajima; Ken-ichi Miyamoto; Keiichi Ozono
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.